Hepatitis and liver disease
NEW YORK, 26 July (Praxis Press) The long-term viral and clinical patterns of hepatitis C virus (HCV) infection are unknown. Thomas and colleagues studied the incidence and determinants of viral clearance and clinical outcome in patients who acquired HCV by injecting drugs. Viral clearance occurred in about 10% of patients during a median follow-up of 8.8 years; clearance occurred more often in non-black patients and in non-HIV-infected patients. End-stage liver disease (ESLD) occurred in about
The Scientist Staff
Jul 26, 2000
NEW YORK, 26 July (
Interested in reading more?
Become a Member of
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member?